Obesity background
Appearance
Nomenclature
[edit | edit source]- Obesity:
- BMI > 30
- %BF >32% (women) or >25% (men)
- Waist circumference >35 inches (women) or >40 inches (men)
- Waist to hip ratio >0.85 (women) or >0.90 (men)
- Abdominal/visceral obesity is much worse than 'gynoid obesity' which is fat in buttock region, more commonly seen in women
- Central obesity causes metabolic syndrome whereas gynoid obesity is less likely to
- Morbid obesity:
- BMI >40
Epidemiology
[edit | edit source]Pathophysiology
[edit | edit source]- In general, there is persistent hunger that is not satiated by the amounts of food that satisfy the non-obese
- This leads to long-term positive energy balance, and accumulation of adipose tissue
- Adipose tissue eventually develops reduced ability to assimilate excess calories
- This leads to fat redistribution to other tissues, causing diverse health consequences
- Metabolic actions of adipose tissue
- Increased secretion of 'adipokines' - leptin, adiponectin, resistin and inflammatory cytokines - comes from white fat, as opposed to brown fat
- Causes chronic low-grade inflammation, interfering with cellular processes, leading to metabolic derangements (T2DM, etc)
- Ghrelin - the 'hunger hormone'
- Levels decrease after meals
- Acts on hypothalamus
- Primarily produced in fundus of stomach
- Regulates hunger together with leptin
- Genetic
- Specific genes - FTO, MC4R - however these only rarely are the sole cause of obesity, and generally become apparent in childhood.
- Syndromes - Prader-Willi (deficits in ghrelin signalling)
- Microbiome
- May be a relationship between gut microbiome and obesity, suggested by some animal studies
- Nutrition
- Hypoalbuminaemia
- Vitamin and micronutrient deficiencies are common
- Weight regain
- Body defends fat vigorously
- Increased hunger, driven by ghrelin
- Decreased energy expenditure, driven by multifactorial neurohormonal changes including reduced SNS input
Edmonton Obesity Scale
[edit | edit source]- Not necessarily directly correlated with BMI
- Predicts mortality
- Large BMI people may even be lower risk mortality than normal
- Do not assume that larger BMI = harmful = need for treatment
Complications
[edit | edit source]- Cardiovascular
- HTN
- MI
- Cardiomyopathy
- DVT
- Pulmonary HTN
- Right heart failure
- Pulmonary
- OSA (35-94% amongst morbidly obese) - benefit from CPAP/BiPAP post-op to avoid hypoxia
- Hypoventilation syndrome of obesity (Pickwickian syndrome)
- Generally seen BMI >60
- Plethoric face, maybe clinically cyanotic, with difficulty at mild exertion
- High haematocrit and PaCO2 > PaO2
- Elevated pulmonary artery pressure
- Asthma
- Metabolic
- Metabolic syndrome
- T2DM (see in 20-30% of bariatric surgery patients)
- Hchol/hyperlipidaemia
- GIT
- GORD
- Cholelithiasis
- NASH cirrhosis - benefit from caloric restriction pre-op
- MSK
- Degenerative joint disease
- Lumbar disc disease
- Osteoarthritis
- Ventral hernias
- Genitourinary
- Stress urinary incontinence
- CKD (diabetes and HTN)
- Gynaecologic
- Menstrual irregularities
- Skin/integumentary system
- Fungal infections
- Boils/abscesses
- Oncologic
- Cancer of thyroid, prostate, oesophagus, kidney, stomach, colon, rectum, GB, pancreas, breast, ovaries, cervix, and endometrium
- Neurologic/psychiatric
- Social